Literature DB >> 27259710

Detection of Shiga toxin-producing and other diarrheagenic Escherichia coli by the BioFire FilmArray® Gastrointestinal Panel in human fecal samples.

K De Rauw1, L Detemmerman2,3, J Breynaert2, D Piérard2.   

Abstract

The purpose of this investigation was the evaluation of the performance of the BioFire FilmArray® Gastrointestinal (FA-GI) Panel, a multiplexed molecular stool screening assay, for the detection of diarrheagenic Escherichia coli (DEC), with emphasis on Shiga toxin-producing E. coli (STEC). A dilution series of 12 STEC reference strains was tested with the FA-GI Panel to assess the analytical sensitivity. A total of 389 patient samples were analyzed with the FA-GI Panel and confirmation of the detected DEC was attempted with an in-house culture-based polymerase chain reaction (PCR) method. All Shiga toxin genes, except the one encoding Stx2f, were detected in bacterial dilutions ranging from 10(4) to 10(2) colony-forming units (CFU)/ml. eae + stx2f + STEC was misclassified as enteropathogenic E. coli (EPEC). Different sensitivities for various gene targets present in one isolate led to differing identifications depending on the concentration. Using the in-house method as a reference, the FA-GI Panel had a sensitivity of 90.6 % [confidence interval (CI) 75.0 %-98.0 %] and a specificity of 97.2 % (CI 94.9 %-98.6 %) for STEC detection in feces. At least one DEC was reported in 35.5 % (171/389) of the patient specimens, with EPEC being the most prevalent (n = 71). Only 59.7 % of the detected DEC could be confirmed, presumably because the comparator method was not applied directly on feces. The FA-GI Panel could not detect the stx2f subtype, misclassified certain pathogens, and the high detection rate of EPEC needs further investigation. Nevertheless, we believe that this sensitive and convenient system will prove to be an invaluable tool for the rapid diagnosis of most DEC infections, but culturing of the detected microorganisms should always be attempted.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27259710     DOI: 10.1007/s10096-016-2688-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  26 in total

Review 1.  Enteropathogenic Escherichia coli: foe or innocent bystander?

Authors:  J Hu; A G Torres
Journal:  Clin Microbiol Infect       Date:  2015-01-28       Impact factor: 8.067

2.  Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis.

Authors:  Sarah N Buss; Amy Leber; Kimberle Chapin; Paul D Fey; Matthew J Bankowski; Matthew K Jones; Margarita Rogatcheva; Kristen J Kanack; Kevin M Bourzac
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

Review 3.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

4.  Enteroaggregative Shiga toxin-producing Escherichia coli of serotype O104:H4 in Belgium and Luxembourg.

Authors:  K De Rauw; S Vincken; L Garabedian; E Levtchenko; I Hubloue; J Verhaegen; J Craeghs; Y Glupczynski; J Mossong; D Piérard
Journal:  New Microbes New Infect       Date:  2014-08-05

5.  A method for fast and simple detection of major diarrhoeagenic Escherichia coli in the routine diagnostic laboratory.

Authors:  S Persson; K E P Olsen; F Scheutz; K A Krogfelt; P Gerner-Smidt
Journal:  Clin Microbiol Infect       Date:  2007-02-28       Impact factor: 8.067

6.  A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons.

Authors:  H Schmidt; J Scheef; S Morabito; A Caprioli; L H Wieler; H Karch
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

7.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

8.  Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.

Authors:  Mohamed A Karmali; Mariola Mascarenhas; Songhai Shen; Kim Ziebell; Shelley Johnson; Richard Reid-Smith; Judith Isaac-Renton; Clifford Clark; Kris Rahn; James B Kaper
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS).

Authors:  Paul N Goldwater; Karl A Bettelheim
Journal:  BMC Med       Date:  2012-02-02       Impact factor: 8.775

Review 10.  O157:H7 and O104:H4 Vero/Shiga toxin-producing Escherichia coli outbreaks: respective role of cattle and humans.

Authors:  Denis Piérard; Henri De Greve; Freddy Haesebrouck; Jacques Mainil
Journal:  Vet Res       Date:  2012-02-13       Impact factor: 3.683

View more
  3 in total

Review 1.  Acute Viral Gastrointestinal (GI) Infections in the Tropics-A Role for Cartridge-Based Multiplex PCR Panels?

Authors:  Stefanie Kramme; Theo Dähne; Alexey Fomenko; Marcus Panning
Journal:  Trop Med Infect Dis       Date:  2022-05-19

2.  Evaluation of a multiplex panel for the diagnosis of acute infectious diarrhea in immunocompromised hematologic patients.

Authors:  Izaskun Alejo-Cancho; Francesc Fernández Avilés; Alicia Capón; Cristina Rodríguez; Josep Barrachina; Pilar Salvador; Mª Eugenia Valls; Miriam J Álvarez-Martínez; Yuliya Zboromyrska; Jordi Vila; Mª Ángeles Marcos
Journal:  PLoS One       Date:  2017-11-03       Impact factor: 3.240

3.  Twenty-seven years of screening for Shiga toxin-producing Escherichia coli in a university hospital. Brussels, Belgium, 1987-2014.

Authors:  Klara De Rauw; Steve Jacobs; Denis Piérard
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.